← Browse by Condition
Medical Condition
her2 negative breast cancer
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2, Phase 3, Phase 1, Phase 2
NCT06568692 Phase 2
Recruiting
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Enrollment
90 pts
Location
United States
Sponsor
Processa Pharmaceuticals
NCT06388122
Recruiting
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients
Enrollment
100 pts
Location
United States
Sponsor
Mayo Clinic
NCT06382948 Phase 3
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
Enrollment
240 pts
Location
Austria, Czechia, Fr...
Sponsor
MedSIR
NCT07218432
Recruiting
A Study of the TheraBionic P1 Device in Breast Cancer
Enrollment
24 pts
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In...
NCT07483307 Phase 2
Recruiting
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer
Enrollment
176 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Enrollment
300 pts
Location
United States, Austr...
Sponsor
PMV Pharmaceuticals, Inc
NCT06650423
Recruiting
Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
Enrollment
319 pts
Location
Slovenia
Sponsor
Institute of Oncology Ljubljan...
NCT05452213 Phase 4
Recruiting
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
Enrollment
1,000 pts
Location
Germany
Sponsor
Institut fuer Frauengesundheit